Top Analyst Upgrades and Downgrades: AngioDynamics, Commercial Metals, Eldorado Resorts, Gamestop, Marvell, Spotify, US Steel and More

Print Email

Altice USA Inc. (NASDAQ: ATUS) was started with an Outperform rating at Macquarie with a target price of $23.50. That compares with a consensus target of $28.71. The 52-week trading range is $17.58 to $35.29. The stock closed Monday at $18.29.

America Movil S.A. (NYSE: AMX) was started with a Buy rating at Goldman Sachs with a $25 price target. That compares with a consensus target of $18.85. The 52-week trading range is $14.09 to $19.52. Shares closed Monday at $18.72.

California Water Service Group (NYSE: CWT) was raised to Market Perform from Underperform at Wells Fargo. The 52-week trading range is $32.75 to $46.15. The consensus price objective is $36.60, and the stock closed Monday at $35.65.

Compass Minerals International Inc. (NYSE: CMP) was started with an Overweight rating at Stephens. The 52-week trading range is $56.50 to $76.65. The Wall Street consensus price objective is posted at $70.57. The stock closed trading on Monday a $59.50.

HFF Inc. (NYSE: HF) was started with a Sell rating and a $41 price target at Goldman Sachs. That compares to the consensus target of $50. The 52-week trading range is $25.85 to $51.74. The stock closed Monday at $49.60.

Oasis Petroleum Inc. (NYSE: OAS) was raised to Outperform from Neutral at Seaport Global Securities. The 52-week trading range is $6.69 to $15.77, and the consensus price target is $12.35. The shares closed Monday at $7.77, down over 4% on the day.

Red Rock Resorts Inc. (NASDAQ: RRR) was downgraded to Neutral from Outperform at Macquarie. The 52-week trading range is $21.41 to $35.77. The consensus price target is posted at $35.60. The shares ended trading on Monday at $28.47.

Trimas Corp. (NASDAQ: TRS) was started with an Outperform rating at BMO Capital Markets. The $33 price target compares with the consensus target of $27.50. The 52-week trading range is $19.75 to $28.85. Shares closed Monday at $25.25.

United Therapeutics Inc. (NASDAQ: UTHR) is raised to Neutral from Underperform at Credit Suisse. The 52-week trading range is $106.30 to $152.55. The consensus price target is $126.17. The stock closed Monday at $107.42, down almost 5%.

In case you missed it, here are Monday’s top analyst upgrades and downgrades. They included Agilent, Allstate, ADP, Baker Hughes, Cardinal Health, Comcast, FitBit, Humana, Tesla and more.

I'm interested in the Newsletter